The Application of Fluidics Technology for Organ Preservation

Biomedical Instrumentation and Technology

Volumn 38, Issue 2, 2004, Pages 155-164

  Bunegin, Leonid ^a,b   Gelineau, Jerry F ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTUATORS; BIOLOGICAL MATERIALS PRESERVATION; BIOLOGICAL ORGANS; FLOW OF FLUIDS; MATHEMATICAL MODELS;

AORTIC FLOW; PERFUSION PRESSURE;

FLUIDICS;

ANIMAL TISSUE; AORTA FLOW; ARTICLE; BIOTECHNOLOGY; DEVICE; DOG; HEART; HYPOTHERMIA; MEDICAL TECHNOLOGY; NONHUMAN; ORGAN PERFUSION; ORGAN PRESERVATION; OXYGEN CONCENTRATION; OXYGENATION; PRESSURE;

EQUIPMENT DESIGN; HUMANS; ORGAN PRESERVATION; PULSATILE FLOW; TRANSPLANTS; UNITED STATES;

EID: 1842628845     PISSN: 08998205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Stringham JC, Love RB, Welter D, Canver CC, Mentzer RM Jr. Impact of University of Wisconsin solution on clinical heart transplantation. A comparison with Stanford solution for extended preservation. Circulation. 1998;98:11157-11161.
2. Havel M, Owen AN, Simon P. Basic principles of cardioplegic management in donor heart preservation. Clin Ther. 1991;13:289-303.
3. Jahania MS, Sanchez JA, Narayan P, Lasley RD, Mentzer RM Jr. Heart preservation for transplantation: principles and strategies. Ann Thorac Surg. 1999;68:1983-1987.
4. Saitoh Y, Hashimoto M, Ku K, et al. Heart preservation in HTK solution: role of coronary vasculature in recovery of cardiac function. Ann Thorac Surg. 2000;69:107-112.
5. Muhlbacher F, Langer F, Mittermayer C. Preservation solutions for transplantation. Transplant Proc. 1999;31: 2069-2070.
6. Perrault LP, Nickner C, Desjardins N, Dumont E, Thai P, Carrier M. Improved preservation of coronary endothelial function with Celsior compared with blood and crystalloid solutions in heart transplantation. J Heart Lung Transplant. 2001;20:549-558
7. Vega JD, Ochsner JL, Jeevanandam V, et al. A multicenter, randomized, controlled trial of Celsior for flush and hypothermic storage of cardiac allografts. Ann Thorac Surg. 2001;71:1442-1447.
8. 2. Math Biosci. 1981;55:231-246.
9. Oshima K, Morishita Y, Yamagishi T, et al. Longterm heart preservation using a new portable hypothermic perfusion apparatus. J Heart Lung Transplant. 1999;18:852-861.
10. Tsutsumi H, Takeyoshi II, Oshima K, Mohara J, Aizaki M, Morishita Y. The effect of coronary perfusion with an oxygenated celsior solution on 12 hour cardiac preservation. Int J Angiol. 2001;10:15-19.
11. Jones BU, Serna DL, Beckham G, et al. Recovery of cardiac function after standard hypothermic storage versus preservation with Peghemoglobin. ASAIO J. 2000;47: 197-201.
12. Smulowitz PB, Serna DL, Beckham GE, Milliken JC. Ex vivo cardiac allograft preservation by continuous perfusion techniques. ASAIO J. 2000;46:389-396.
13. Nutt MP, Fields BL, Sebree LA, et al. Assessment of function, perfusion, metabolism, and histology in hearts preserved with University of Wisconsin solution. Circulation. 1992;86:11333-11338.
14. Miller LW, Jellinek M, Codd JE, Kolata RJ. Improved myocardial preservation by control of the oxidation reduction potential. J Heart Transplant. 1985;4:319-324.
15. O'Dell B, Bunegin L. Combined Perfusion and Oxygenation Apparatus. US patent 5 362 622. 1994.
16. Augrist SW. Fluid control devices. Sci Am. 1964;211:81.
17. Collins GM, Bravo-Shugarman M, Teraski PI. Kidney preservation for transplantation: initial perfusion and 30 hour ice storage. Lancet. 1969;2:1219.
18. Bretschneider H, Hubner G, Knoll D, Lohr B, Nordbeck H, Spiekermann P. Myocardial resistance and tolerance to ischemia. J Cardiovasc Surg. 1975;16:241.
19. Balupuri S, Mantle D, Mohamed M, et al. Machine perfusion and viability assessment of non-heart-beating donor kidneys- a single center result. Transplant Proc. 2001;33: 1119-1120.
20. Hansen TN, D'Alessandro A, Southard JH. Reduced renal vascular injury following warm ischemia and preservation by hypothermic machine perfusion. Transplant Proc. 1997;29:3577-3579.
21. Balupuri S, Strong A, Hoernich N, et al. Machine perfusion for kidneys: how to do it at minimal cost. Transpl Int. 2001;14:103-107.
22. Iwamoto H, Matsuno N, Narumi Y, et al. Beneficial effects of machine perfusion preservation on liver transplantation from non-heart-beating donors. Transplant Proc. 2000;32:1645-1646.
23. Daemen JCH, de Vries B, Kootstra G. The effect of machine perfusion preservation on early function of non-heart-beating donor kidneys. Transplant Proc. 1997;29; 3489.
24. Daemen JCH, de Vries B, Oomen APA, DeMeester J, Kootstra G. The effect of machine perfusion preservation on delayed graft function in non-heart-beating donor kidneys-early results. Transpl Int. 1997;10(4);317-322.
25. Kim JS, Boudjema K, D'Alessandro A, Southard JH. Machine perfusion of the liver: maintenance of mitochondrial function after 48-hour preservation. Transplant Proc. 1997;29:3452-3454.
26. Szust J, Olson L, Cravero L. A comparison of OPO pusatile machine preservation practices and results. J Transpl Coord. 1999;9:97-100.
27. 1 influences pulsatile preservation characteristics and early graft function in expanded criteria donor kidneys. J Surg Res. 1999;85:17-25.
28. Cooper DKC, Wicomb WN, Barnard CN. Storage of the donor heart by a portable hypothermic perfusion system: experimental development and clinical experience. Heart Transplant. 1983;2:104.
29. Wicomb WN, Cooper DKC, Novitsky D, Barnard CN. Cardiac transplantation following storage of the donor heart by a portable hypothermic perfusion system. Ann Thorac Surg. 1984;37:243.
30. Rizvi SAH. Non-heart-beating donor transplantation: machine perfusion preservation is the answer to prolonged cold ischemia time. Transplant Proc. 2000;32: 143.
31. Manciet LH, Larson DF, Copeland JG. Low pressure perfusion results in effective microvascular perfusion of isolated rabbit hearts during hypothermic preservation for twenty-four hours. J Heart Lung Transplant. 1991;10:710.
32. Mendler N, Strucle E, Sebening R. Orthotopic canine heart transplantation after 24 hours cold perfusion. Transplant Proc. 1984;16:173.
33. Pereyra LH, Chee M, Lillehei RC. Effects of pulsatile perfusion and storage on hearts preserved for 24 hours under hypothermia for transplantation. Ann Thorac Surg. 1979;27:24.
34. Arnaud FG, Khirabadi BS, Fahy GM. Normothermic blood perfusion of isolated kidneys. III. In vivo physiology of kidneys after perfusion with Euro-Collins solution or 7.5M cryoprotectant (VS4). Transpl Int. 2002;15:287-289.
35. Wicomb WN, Wood J, Hill JD, Bry WI, Collins GM. Value of polyethylene glycol (PEG) and horseradish peroxidase (HRP) for hypothermic rabbit heart perfusion. Transplant Proc. 1989;21:1366-1368.
36. Coanda H. Procede de propulsion dans un fluide. Brevet Invent Gr Cl 2 no 762688 Republique Francaise. 1932.
37. Reba I. Applications of the Coanda effect. Sci Am. 1966; 214:84.
38. Watson PF, Morris GJ. Cold shock injury in animal cells. Soc Exp Biol. 1987;311-337.
39. Takahashi A, Hearse DJ, Braimbridge MV, Chambers DJ. Harvesting hearts for long-term preservation. J Thorac Cardiovasc Surg. 1990;100:371-378.
40. Humphrey SM, Choong YS, Buckman JE, Gavin JB. Influence of storage volume on functional recovery and metabolism of explanted hearts following cold cardioplegia: studies in the rat. Cardiovasc Res. 1991;25:719.
41. de Boer J, Postema F, Plijter-Groendijk H, Korf J. Continuous monitoring of extracellular lactate concentration by microdialysis lactography for the study of rat muscle metabolism in vivo. Euro J Physiol. 1991;419:1-6.
42. Van Wylen DGL, Willis J, Sohhi J, Weiss RJ, Lasley RD, Mentzer RM. Cardiac microdialysis to estimate interstitial adenosine and coronary blood flow. Am J Physiol. 1990;258:H1642-H1649.
43. Hoffman RM, Stratta RJ, D'Alessandro AM, et al. Combined cold storage-perfusion preservation with a new synthetic perfusate. Transplantation. 1989;47:32-37.
44. Henry ML, Sommer BG, Ferguson RM. Improved immediate function of renal allografts with belzer perfusate. Transplantation. 1988;45:73-75.
45. Calhoon JH, Bunegin L, Gelineau JF, et al. Twelve-hour canine heart preservation with a simple, portable hypothermic organ perfusion device. Ann Thorac Surg. 1996;62:91-93.
46. Bunegin L, Gelineau F. Application of fluidics based technology for perfusion preservation of adult, human sized canine hearts. Cardiovasc Eng. 2002;7:1-6.